Search

Author/Creator Gu, Yangchun

1. Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China. Issue 1 (1st December 2021)

Authors:
Zou, Zihua; Hao, Xuezhi; Zhang, Cuiying; Li, Haojing; Dong, Guilan; Peng, Yumei; Ma, Kewei; Guo, Ye; Shan, Li; Zhang, Yan; Liang, Li; Gu, Yangchun; Xing, Puyuan; Li, Junling
Journal:
Thoracic cancer
Issue:
Volume 13:Issue 1(2022)
Page Start:
107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma. Issue 3 (21st February 2017)

Authors:
Guo, Ziwei; Yi, Fumei; Yin, Wencheng; Zhang, Yu; Li, Qian; Gu, Yangchun; Xiao, Yu; Cao, Baoshan; Ma, Liwen; Liang, Li
Journal:
Thoracic cancer
Issue:
Volume 8:Issue 3(2017)
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Different patterns of treatment‐related adverse events of programmed cell death‐1 and its ligand‐1 inhibitors in different cancer types: A meta‐analysis and systemic review of clinical trials. Issue 5 (10th August 2020)

Authors:
Gu, Yangchun; Zhang, Hua; Liu, Zexiang; Xia, Yifan; Liang, Baosheng; Liang, Li
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 16:Issue 5(2020)
Page Start:
e160
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China. Issue 3 (21st December 2021)

Authors:
Shi, Yuequan; Fang, Jian; Zhou, Chengzhi; Liu, Anwen; Wang, Yan; Meng, Qingwei; Ding, Cuimin; Ai, Bin; Gu, Yangchun; Yao, Yu; Sun, Hong; Guo, Hui; Zhang, Cuiying; Song, Xia; Li, Junling; Xu, Bei; Han, Zhiqiang; Song, Meijun; Tang, Tingyu; Chen, Peifeng
Journal:
Thoracic cancer
Issue:
Volume 13:Issue 3(2022)
Page Start:
412
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study. Issue 7 (29th May 2019)

Authors:
Liang, Hongge; Song, Xia; Zhang, Yuhui; Zhang, Shucai; Li, Fang; Fang, Jian; Li, Junling; Liang, Li; Nie, Ligong; Ma, Kewei; Zhang, Liangming; Wang, Xiaohong; Xu, Junjun; Wei, Yanxia; Wang, Jinghui; Song, Qi; Tian, Guangming; Mu, Yuxin; Gu, Yangchun; Yang, Lei
Journal:
Thoracic cancer
Issue:
Volume 10:Issue 7(2019)
Page Start:
1521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique. Issue 23 (14th October 2021)

Authors:
Gu, Yangchun; Xu, Yan; Zhuang, Hongqing; Jiang, Weijuan; Zhang, Hua; Li, Xiaofeng; Liu, Yonggang; Ma, Li; Zhao, Dahai; Cheng, Yuan; Yu, Yan; Liu, Ping; Qin, Jianwen; Chen, Xueqin; Gao, Junzhen; Wang, Mengzhao; Liang, Li; Cao, Baoshan
Journal:
Thoracic cancer
Issue:
Volume 12:Issue 23(2021)
Page Start:
3157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗